Avenova® is made by NovaBay® Pharmaceuticals of Emeryville, California. With its Avenova brand, NovaBay focuses on the development and marketing of revolutionary products that address unmet medical needs. Other brands address similar needs in wound care and dermatology.
NovaBay has developed a family of products based on a skin cleansing technology, Neutrox®, proprietary pure hypochlorous acid (HOCl). The initial wound care product, NeutroPhase®, was cleared by the FDA “for use under the supervision of healthcare professionals for cleansing and removal of foreign material, including microorganisms and debris from wounds, and for moistening absorbent wound dressings and cleaning minor cuts, minor burns, superficial abrasions, and minor irritations of the skin. It is also intended for moistening and debriding acute and chronic dermal lesions, such as Stage I to IV pressure ulcers, stasis ulcers, leg ulcers, diabetic foot ulcers, post-surgical wounds, first and second-degree burns, and grafted and donor sites.”
Following the initial 510(k) clearance, NovaBay developed two additional products within the original 510(k) intended use, but for unique, specific indications: Avenova® for eyelid & eyelash hygiene and CelleRx® for use associated with cosmetic procedures.
Avenova is also used as a part of the eyelid and lash hygiene regimen for pre-surgical LASIK and cataract patients, for retinal patients receiving regular intravitreal injections and contact lens patients.
NovaBay employs direct sales representatives and Avenova is available in pharmacies nationwide. The product’s sales have continued to grow as satisfied patients have used the product daily as part of their eyelid and lash hygiene regimens.